Studies on the mechanisms of glucocorticoid hypertension in humans

J A Whitworth1

  • 1Department of Medicine, St. George Hospital, University of New South Wales, Kogarah, Australia.

Blood Pressure
|March 1, 1994
PubMed

Insights

Glucocorticoid-induced hypertension, common in Cushing's syndrome and steroid use, does not stem from sodium retention. Instead, increased pressor responsiveness may drive elevated blood pressure in these conditions.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension is a significant complication of Cushing's syndrome and exogenous steroid administration.
  • Cardiovascular risks are elevated in patients with glucocorticoid-induced hypertension.
  • The underlying mechanisms of this hypertension are not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of glucocorticoid-induced hypertension.
  • To determine if sodium retention or volume expansion contributes to elevated blood pressure.
  • To explore the role of pressor responsiveness in glucocorticoid hypertension.

Main Methods:

  • Review of existing literature on glucocorticoid-induced hypertension.
  • Analysis of patient data from studies on Cushing's syndrome and iatrogenic steroid use.
  • Assessment of physiological parameters related to blood pressure regulation.

Main Results:

  • Glucocorticoid-induced hypertension is not associated with significant urinary sodium retention.
  • Volume expansion does not appear to be the primary driver of hypertension.
  • Increased pressor responsiveness to vasoconstrictors is implicated as a key factor.

Conclusions:

  • The mechanism of glucocorticoid-induced hypertension in humans is complex and multifactorial.
  • Elevated pressor responsiveness is a likely contributor to hypertension in these conditions.
  • Further research is needed to fully elucidate the pathophysiology and guide therapeutic strategies.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...